Concepedia

Arindom Pal

AP

Statistics

Publications

10

Citations

530

H-Index

10

Active since

2013

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

University of the Pacific

Arindom Pal is an author at Johns Hopkins Medicine specializing in pharmacology, medicine, and drug delivery.

Publications per year

2013–2023

10

Publications

10

A biomimetic approach for enhancing the in vivo half-life of peptides

Sravan Penchala, Mark R. Miller, Arindom Pal et al. · Nature Chemical Biology · 2015 · 137 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacokinetics +14

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

Rana Rais, Kathryn M. Lemberg, Lukáš Tenora et al. · Science Advances · 2022 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis

Mark R. Miller, Arindom Pal, Wabel Albusairi et al. · Journal of Medicinal Chemistry · 2018 · 103 citations · Full text

Medicine, Molecular Biology, Pharmacology +15

Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury

Carolyn Tallon, Silvia Picciolini, Seung‐Wan Yoo et al. · Biochemical Pharmacology · 2021 · 42 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents

Arindom Pal, Wabel Albusairi, Fang Liu et al. · Molecular Pharmaceutics · 2019 · 27 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–5 of 10